News
06-16-2010, 05:30 AM
Patients are emerging as an increasingly strong group when it comes to influencing the success and failure of new drugs - according to a newly published New Health Report commissioned by Quintiles to gauge the opinions of biopharma executives, managed care executives and patients, and to track progress in the New Health.
More... (http://www.news-medical.net/news/20100616/Report-reveals-increase-in-patients-influence-on-success-failure-of-new-drugs.aspx)
More... (http://www.news-medical.net/news/20100616/Report-reveals-increase-in-patients-influence-on-success-failure-of-new-drugs.aspx)